TKT and chronic myelogenous leukemia, BCR-ABL1 positive: An example is the well-established relationship between constitutively active Bcr-Abl tyrosine kinase (TK) expression and the leukemic phenotype associated with CML (chronic myelogenous leukemia) [23].